Extensively drug-resistant tuberculosis; (XDR TB)

i

Extensively drug-resistant tuberculosis; (XDR TB)

Public Domain

February 2009
By National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Series: TB Elimination

Details

Alternative Title:

XDR TB
Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Description:

"Extensively drug-resistant tuberculosis (XDR TB) is a relatively rare type of multidrug-resistant tuberculosis (MDR TB). It is resistant to almost all drugs used to treat TB, including the two best first-line drugs: isoniazid and rifampin. XDR TB is also resistant to the best second-line medications: fluoroquinolones and at least one of three injectable drugs (i.e., amikacin, kanamycin, or capreomycin). (World Health Organization [WHO] definition for cases detected on initial susceptibility testing.)." - p. 1
Subjects:

Tuberculosis, Multidrug-Resistant
Series:

TB Elimination
Document Type:

Text
Genre:

Patient Education Handout ; Fact Sheet
Place as Subject:

United States
Pages in Document:

electronic resource; remote; 3 p. : digital, PDF file (325 KB, 3 p.)
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha-512:da4bd404055b643e41d0e1acfa4e2eaef73e654e0bf80264089d9b373f5a0a6369145229ece2c1a0d41901cbe3d50febb0bf05e303409055764e944c6f1c5b62
Download URL:

https://stacks.cdc.gov/view/cdc/5882/cdc_5882_DS1.pdf
File Type:

[PDF - 326.24 KB ]

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.